Physician profile
Peter David Highlander
NPI 1285921072
$107,510.25
in general payments reported to CMS, 2019-2025
16 companies · $12K in 2025
The $12K reported for 2025 was more than what 96% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $21K · 2021: $9,115 · 2022: $17K · 2023: $17K · 2024: $14K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $24K · Royalty Or License: $13K · Travel and Lodging: $6,176 · Food and Beverage: $897.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $23,720.54 |
| Royalty Or License | $12,752.04 |
| Travel and Lodging | $6,175.83 |
| Food and Beverage | $897.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Restor3d, INC. | $69,799.91 | 2019-2025 | |
| Vilex LLC | $12,173.48 | 2024-2025 | Redemption |
| Medshape, INC. | $6,895.33 | 2019-2020 | |
| Additive Orthopaedics, LLC | $6,322.80 | 2019 | |
| Osteomed LLC | $5,913.86 | 2019-2020 | |
| Integra Lifesciences Corporation | $4,213.48 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Paragon 28, INC. | $898.29 | 2019-2024 | Bun-Yo-Matic |
| Stryker Corporation | $463.63 | 2019-2021 | |
| Wright Medical Technology, INC. | $385.24 | 2019-2020 | |
| Smith+Nephew, INC. | $220.67 | 2019-2022 | |
| Arteriocyte Medical Systems, INC. | $70.50 | 2019 | |
| Organogenesis INC. | $59.00 | 2022-2024 | Nushield |
| Gramercy Extremity Orthopedics LLC | $34.00 | 2020 | |
| Lifenet Health | $26.73 | 2023 | |
| Nabriva Therapeutics, Plc | $20.22 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $13.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$25,201.84 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Highlander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.